SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030690
Filing Date
2023-11-07
Accepted
2023-11-07 17:23:43
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20230930_10q.htm   iXBRL 10-Q 1382491
2 EXHIBIT 31.1 ex_561758.htm EX-31.1 13785
3 EXHIBIT 31.2 ex_561759.htm EX-31.2 13986
4 EXHIBIT 32.1 ex_561760.htm EX-32.1 7029
5 EXHIBIT 32.2 ex_561761.htm EX-32.2 7305
  Complete submission text file 0001437749-23-030690.txt   6944854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zvra-20230930.xsd EX-101.SCH 64745
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zvra-20230930_cal.xml EX-101.CAL 56516
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20230930_def.xml EX-101.DEF 461543
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20230930_lab.xml EX-101.LAB 417270
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20230930_pre.xml EX-101.PRE 481632
60 EXTRACTED XBRL INSTANCE DOCUMENT zvra20230930_10q_htm.xml XML 1016399
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 231385171
SIC: 2834 Pharmaceutical Preparations